Menzies Centre for Health Policy

Menzies Centre for Health Policy

The Menzies Centre for Health Policy (MCHP) is the leading independent scholarly voice on health policy in Australia. It brings together scholars and practitioners with broad expertise in health policy, economics and health services research to produce high-quality analyses of current health policy issues, deliver annual public seminars, education programs and undertake comprehensive research projects. MCHP’s research program addresses five themes that include policies for health futures, value in health care, serious and continuing illness, equity and governance.

News Publications and Events

Professor Adam Elshaug appointed to the Board of the Bureau of Health Information (BHI)


Congratulations to Professor Adam Elshaug on his appointment to the Board of the NSW Bureau of Health Information (BHI). Professor Elshaug is "...honoured to accept this role. I believe the BHI has shown incredible foresight, leadership and ingenuity in managing and reporting health system performance data that is driving real improvements.

Editorial: Cancer in small states – No small matter, Cancer Epidemiology, Volume 50, Part B, October 2017, Pages 173-175

Adjunct Associate Professor Frederic (Freddy) Sitas comments: "The supplement shows much is still needed to be done in our part of the world, the Pacific region, comprising over  25,000 islands. Establishing effective cancer registration, prevention and screening programs and clear referral pathways with neighbouring countries were identified as key priorities."

Professor Natasha Nassar appointed Financial Markets Foundation for Children Chair of Translational Childhood Medicine

Congratulations to Professor Natasha Nassar who has been appointed as the Financial Markets Foundation for Children Chair of Translational Childhood Medicine at the University of Sydney. 

Read more

 

Publication: Older cancer patients in cancer clinical trials are underrepresented, Cancer Epidemiol. 2017 Nov 7;51:113-117.  Authors: Dunn C, Wilson A, Sitas F.

Adjunct Associate Professor Frederic (Freddy) Sitas comments: "This publication reviewed almost 5000 pooled or meta-analyses of cancer clinical trials and found only one had patients that represented the age breakdown of the background population.  In the rest, all patients were younger than the background population.  With cancer survival dropping sharply between 65-74 and 75-84 years, clinical trials research in older populations is important to identify more effective treatments. +